Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)

Market Cap	9.34B -24.2%
Revenue (ttm)	2.73B -9.5%
Net Income	266.27M -43.3%
EPS	1.15 -42.9%
Shares Out	225.44M
PE Ratio	19.10
Forward PE	n/a
Dividend	1.15 (5.23%)
Ex-Dividend Date	Jun 4, 2026

Volume	133,660
Average Volume	181,895
Open	22.20
Previous Close	21.98
Day's Range	21.90 - 22.40
52-Week Range	20.94 - 31.28
Beta	0.54
RSI	48.54
Earnings Date	Apr 24, 2026

About HKG:6826

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 2,110
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6826

Financial Performance

In 2025, HKG:6826's revenue was 2.45 billion, a decrease of -8.71% compared to the previous year's 2.68 billion. Earnings were 251.01 million, a decrease of -40.30%.

Financial numbers in CNY